The Employers’ Guide to GLP-1s

White Paper Obesity care and GLP-1s

Summary

As the demand for GLP-1s continues to surge, it’s no surprise they’re now among the top-cost drugs for employers. In this white paper, learn everything you need to know about GLP-1s to guide your obesity care strategy.

Ozempic and Mounjaro side effects

Download the White Paper

By submitting this form, I understand that Noom will process my personal information in accordance with their Privacy Policy.

Related Content

  • Blog
  • Obesity care and GLP-1s
  • September 28
  • 2 min read

Noom Med Offers Employers a Cost-Effective Solution for Weight Loss Drugs

By Noom Team

  • Blog
  • Obesity care and GLP-1s
  • February 5
  • 1 min read

Unlocking Lasting Change with Noom’s 4-C’s

By Noom Team

  • Blog
  • Obesity care and GLP-1s
  • May 1
  • 1 min read

Employer Strategies for Maximizing the Promise of GLP-1s

By Noom Team

Bring Noom to
your organization

Give your workforce a preview of what’s possible
for their physical and mental health.

REQUEST DEMO